OASL anticorps (C-Term)

N° du produit ABIN390168

Détail du produit anti-OASL anticorps

Antigène: OASL (2'-5'-Oligoadenylate Synthetase-Like (OASL))

Épitope: AA 484-514, C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp OASL est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Purification: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogène: This OASL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 484-514 amino acids from the C-terminal region of human OASL.

Clone: RB1948

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Date de péremption: 6 months

Références pour anticorps anti-OASL (ABIN390168)

Forero, Giacobbi, McCormick, Gjoerup, Bakkenist, Pipas, Sarkar: "Simian virus 40 large T antigen induces IFN-stimulated genes through ATR kinase." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 12, pp. 5933-42, (2014) (PubMed).

Forero, Moore, Sarkar: "Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 191, Issue 3, pp. 1476-85, (2013) (PubMed).

Ishibashi, Wakita, Esumi: "2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro." dans: Biochemical and biophysical research communications, Vol. 392, Issue 3, pp. 397-402, (2010) (PubMed).

Détails sur OASL

Antigène: OASL (2'-5'-Oligoadenylate Synthetase-Like (OASL))

Autre désignation: OASL (OASL Produits)

Synonymes: anticorps Oasl1, anticorps oasl9, anticorps 7530414C13Rik, anticorps OASLd, anticorps TRIP-14, anticorps TRIP14, anticorps p59 OASL, anticorps p59-OASL, anticorps p59OASL, anticorps 2'-5'-oligoadenylate synthetase-like, anticorps 2'-5' oligoadenylate synthetase-like 1, anticorps 2'-5'-oligoadenylate synthetase like, anticorps 2'-5'-oligoadenylate synthase-like protein, anticorps Oasl, anticorps Oasl1, anticorps OASL, anticorps LOC100356242, anticorps LOC100483471

Sujet: 2-prime,5-prime oligoadenylates (2-5As) bind to and activate RNase L, leading to degradation of RNA and inhibition of protein synthesis. 2-5As are produced by 2-5A synthetases (OASs), a highly-conserved family of interferon-induced enzymes. The predicted 514-amino acid human p59OASL (2-5A synthetases-like) protein shares a highly conserved N-terminal domain with other OASs. The C-terminal portion of p59OASL contains 2 ubiquitin-like domains. p59OASL is expressed in most tissues, with the highest levels in hematopoietic tissues, colon, and stomach.

Poids moléculaire: 59226

ID gène: 8638

NCBI Accession: NP_001248754, NP_003724, NP_937856

UniProt: Q15646